Bile acids alter the subcellular localization of CNT2 (concentrative nucleoside cotransporter) and increase CNT2-related transport activity in liver parenchymal cells

Biochemical Journal

Volumn 395, Issue 2, 2006, Pages 337-344

  Fernández Veledo, Sonia ^b   Huber Ruano, Isabel ^a   Aymerich, Ivette ^a   Duflot, Sylvie ^a   Casado, F Javier ^a   Pastor Anglada, Marçal ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Adenosine; Bile acids; CNT2; Liver parenchymal cells; Plasma membrane transporters; Trafficking

Indexed keywords

AGENTS; BIOLOGICAL ORGANS; CELLS; FRACTIONATION; PHYSIOLOGY; PROTEINS;

ADENOSINE; BILE ACIDS; CNT2; LIVER PARENCHYMAL CELLS; PLASMA MEMBRANE TRANSPORTERS;

ORGANIC ACIDS;

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM); BILE ACID; BUCLADESINE; COLCHICINE; DEOXYCHOLIC ACID; GLYCOCHENODEOXYCHOLIC ACID; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN CNT2; STREPTAVIDIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; WORTMANNIN; YELLOW FLUORESCENT PROTEIN; CARRIER PROTEIN; CIF NUCLEOSIDE TRANSPORTER; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; ANIMAL; CELL CULTURE; GENETICS; LIVER CELL; METABOLISM; SIGNAL TRANSDUCTION; TIME; UPREGULATION; WISTAR RAT;

ANIMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BILE ACIDS AND SALTS; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEPATOCYTES; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; PROTEIN TRANSPORT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TAUROCHOLIC ACID; TIME FACTORS; UP-REGULATION;

EID: 33645768125     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20051232     Document Type: Article

References (49)

1. Kong, W., Engel, K. and Wang, J. (2004) Mammalian nucleoside transporters. Curr. Drug Metab. 5, 63-84
2. Gray, J. H., Owen, R. P. and Giacomini, K. M. (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 447, 728-734
3. Pastor-Anglada, M., Molina-Arcas, M., Casado, F. J., Bellosillo, B., Colomer, D. and Gil, J. (2004) Nucleoside transporters in chronic lymphocytic leukaemia. Leukemia 18, 385-393
4. +-nucleoside cotransporter. J. Biol. Chem. 270, 13596-13599
5. Valdes, R., Ortega, M. A., Casado, F. J., Felipe, A., Gil, A., Sanchez-Pozo, A. and Pastor-Anglada, M. (2000) Nutritional regulation of nucleoside transporter expression in rat small intestine. Gastroenterology 119, 1623-1630
6. Soler, C., Valdes, R., Garcia-Manteiga, J., Xaus, J., Comalada, M., Casado, F. J., Modolell, M., Nicholson, B., MacLeod, C., Felipe, A. et al. (2001) Lipopolysaccharide-induced apoptosis of macrophages determines the up-regulation of concentrative nucleoside transporters Cnt1 and Cnt2 through tumor necrosis factor-α-dependent and -independent mechanisms. J. Biol. Chem. 276, 30043-30049
7. Soler, C., Garcia-Manteiga, J., Valdes, R., Xaus, J., Comalada, M., Casado, F. J., Pastor-Anglada, M., Celada, A. and Felipe, A. (2001) Macrophages require different nucleoside transport systems for proliferation and activation. FASEB J. 15, 1979-1988
8. Duflot, S., Calvo, M., Casado, F. J., Enrich, C. and Pastor-Anglada, M. (2002) Concentrative nucleoside transporter (rCNT1) is targeted to the apical membrane through the hepatic transcytotic pathway. Exp. Cell Res. 281, 77-85
9. del Santo, B., Valdes, R., Mata, J., Felipe, A., Casado, F. J. and Pastor-Anglada, M. (1998) Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells. Hepatology 28, 1504-1511
10. +-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells. Biochem. J. 330 (Pt 2), 997-1001
11. Dragan, Y., Valdes, R., Gomez-Angelats, M., Felipe, A., Javier Casado, F., Pitot, H. and Pastor-Anglada, M. (2000) Selective loss of nucleoside carrier expression in rat hepatocarcinomas. Hepatology 32, 239-246
12. +/ nucleoside cotransporter 1 (hCNT1) and role of adenosine on hCNT1 function. J. Biol. Chem. 279, 8999-9007
13. +-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes. J. Physiol. 558, 807-823
14. + channels regulate the concentrative adenosine transporter CNT2 following activation by A1 adenosine receptors. Mol. Cell. Biol. 24, 2710-2719
15. Marin, J. J., Barbero, E. R., Herrera, M. C., Tabernero, A. and Monte, M. J. (1993) Bile acid-induced modifications in DNA synthesis by the regenerating perfused rat liver. Hepatology 18, 1182-1192
16. Villanueva, G. R., Monte, M. J., Barbero, E. R., Serrano, M. A. and Marin, J. J. (1996) Evidence for dual effect of bile acids on thymidine anabolism and catabolism by the regenerating rat liver. Biochim. Biophys. Acta 1289, 136-144
17. Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D. and Lehmann, J. M. (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science (Washington DC) 284, 1365-1368
18. Walters, J. R. (2000) Bile acids are physiological ligands for a nuclear receptor. Gut 46, 308-309
19. Sirvent, A., Verhoeven, A. J., Jansen, H., Kosykh, V., Darteil, R. J., Hum, D. W., Fruchart, J. C. and Staels, B. (2004) Farnesoid X receptor represses hepatic lipase gene expression. J. Lipid Res. 45, 2110-2115
20. Pircher, P. C., Kitto, J. L., Petrowski, M. L., Tangirala, R. K., Bischoff, E. D., Schulman, I. G. and Westin, S. K. (2003) Farnesoid X receptor regulates bile acid-amino acid conjugation. J. Biol. Chem. 278, 27703-27711
21. Kast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M. and Edwards, P. A. (2001) Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol. Endocrinol. 15, 1720-1728
22. +-dependent bile salt uptake by WIF-B cells, a rat hepatoma hybrid cell line, following growth in the presence of a physiological bile salt. Hepatology 27, 191-199
23. Kurz, A. K., Graf, D., Schmitt, M., Vom Dahl, S. and Haussinger, D. (2001) Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology 121, 407-419
24. Gao, B., St Pierre, M. V., Stieger, B. and Meier, P. J. (2004) Differential expression of bile salt and organic anion transporters in developing rat liver. J. Hepatol. 41, 201-208
25. Trauner, M. and Boyer, J. L. (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 83, 633-671
26. Tanaka, F., Hori, N. and Sato, K. (2002) Identification of differentially expressed genes in rat hepatoma cell lines using subtraction and microarray. J. Biochem. (Tokyo) 131, 39-44
27. Gomez-Angelats, M., del Santo, B., Mercader, J., Ferrer-Martinez, A., Felipe, A., Casado, J. and Pastor-Anglada, M. (1996) Hormonal regulation of concentrative nucleoside transport in liver parenchymal cells. Biochem. J. 313 (Pt 3), 915-920
28. +/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol. Membr. Biol. 15, 203-211
29. +-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J. Biol. Chem. 276, 2914-2927
30. Garcia, F., Kierbel, A., Larocca, M. C., Gradilone, S. A., Splinter, P., LaRusso, N. F. and Marinelli, R. A. (2001) The water channel aquaporin-8 is mainly intracellular in rat hepalocytes, and its plasma membrane insertion is stimulated by cyclic AMP. J. Biol. Chem. 276, 12147-12152
31. + nucleoside cotransporter CNT2. J. Cereb. Blood Flow Metab. 21, 929-936
32. Valverde, A. M., Lorenzo, M., Navarro, P. and Benito, M. (1997) Phosphatidylinositol 3-kinase is a requirement for insulin-like growth factor I-induced differentiation, but not for mitogenesis, in fetal brown adipocytes. Mol. Endocrinol. 11, 595-607
33. Fernandez-Veledo, S., Valdes, R., Wallenius, V., Casado, F. J. and Pastor-Anglada, M. (2004) Up-regulation of the high-affinity pyrimidine-preferring nucleoside transporter concentrative nucleoside transporter 1 by tumor necrosis factor-α and interleukin-6 in liver parenchymal cells. J. Hepatol. 41, 538-544
34. Stravitz, R. T., Rao, Y. P., Vlahcevic, Z. R., Gurley, E. C., Jarvis, W. D. and Hylemon, P. B. (1996) Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 α-hydroxylase. Am. J. Physiol. 271, G293-G303
35. Rust, C., Karnitz, L. M., Paya, C. V., Muscat, J., Simari, R. D. and Gores, G. J. (2000) The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 275, 20210-20216
36. Gupta, S., Stravitz, R. T., Dent, P. and Hylemon, P. B, (2001) Down-regulation of cholesterol 7α-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J. Biol. Chem. 276, 15816-15822
37. Kubitz, R., Sutfels, G., Kuhlkamp, T., Kolling, R. and Haussinger, D. (2004) Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Gastroenterology 126, 541-553
38. Wakabayashi, Y., Lippincott-Schwartz, J. and Arias, I. M. (2004) Intracellular trafficking of bile salt export pump (ABCB11) in polarized hepatic cells: constitutive cycling between the canalicular membrane and rab11-positive endosomes. Mol. Biol. Cell 15, 3485-3496
39. Schoemaker, M. H., Conde de la Rosa, L., Buist-Homan, M., Vrenken, T. E., Havinga, R., Poelstra, K., Haisma, H. J., Jansen, P. L. and Moshage, H. (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39, 1563-1573
40. Torchia, E. C., Stolz, A. and Agellon, L. B. (2001) Differential modulation of cellular death and survival pathways by conjugated bile acids. BMC Biochem. 2, 11
41. Bernstein, C., Payne, C. M., Bernstein, H. and Garewal, H. (2002) Activation of the metallothionein IIA promoter and other key stress response elements by ursodeoxycholate in HepG2 cells: relevance to the cytoprotective function of ursodeoxycholate. Pharmacology 65, 2-9
42. Lapenna, D., Ciofani, G., Festi, D., Neri, M., Pierdomenico, S. D., Giamberardino, M. A. and Cuccurullo, F. (2002) Antioxidant properties of ursodeoxycholic acid. Biochem. Pharmacol. 64, 1661-1667
43. Rodrigues, C. M., Sola, S., Sharpe, J. C., Moura, J. J. and Steer, C. J. (2003) Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. Biochemistry 42, 3070-3080
44. +- nucleoside purine (N1) transporter. Pharm. Res. 15, 950-952
45. Mangia, A., Ricci, G. L., Persico, M., Minerva, N., Carretta, V., Bacca, D., Cela, M., Piattelli, M., Annese, M., Maio, G. et al. (2005) A randomized controlled trial of pegylated interferon-α-2a (40 Kd) or interferon-α-2a plus ribavirin and amantadine vs interferon-α-2a and ribavirin in treatment-naive patients with chronic hepatitis C. J. Viral Hepat. 12, 292-299
46. Teuber, G., Berg, T., Hoffmann, R. M., Leifeld, L., Lafrenz, M., Spengler, U., Pape, G. R., Hopf, U. and Zeuzem, S. (2000) Retreatment with interferon-α and ribavirin in primary interferon-α non-responders with chronic hepatitis C. Digestion 61, 90-97
47. Azzaroli, F., Accogli, E., Nigro, G., Trere, D., Giovanelli, S., Miracolo, A., Lodato, F., Montagnani, M., Tame, M., Colecchia, A. et al. (2004) Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. World J. Gastroenterol. 10, 3099-3102
48. Berg, T., Hoffmann, R. M., Teuber, G., Leifeld, L., Lafrenz, M., Baumgarten, R., Spengler, U., Zeuzem, S., Pape, G. R. and Hopf, U. (2000) Efficacy of a short-term ribavirin plus interferon-α combination therapy followed by interferon-α alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial. Liver 20, 427-436
49. Boucher, E., Jouanolle, H., Andre, P., Ruffault, A., Guyader, D., Moirand, R., Turlin, B., Jacquelinet, C., Brissot, P. and Deugnier, Y. (1995) Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients. Hepatology 21, 322-327